MICHAEL LOKALE: Open Payments
NPI 1205147964 · ORO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,423 in 140 payments from 26 companies in 2025. Trend: 2023 $1,759 · 2024 $2,764 · 2025 $2,423
Food & beverage: $2,423
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 24 | $382 |
| ABBVIE INC. | 16 | $323 |
| Amgen Inc. | 21 | $281 |
| Exact Sciences Corporation | 11 | $198 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $149 |
| PFIZER INC. | 11 | $149 |
| Novo Nordisk Inc | 5 | $88 |
| Lilly USA, LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 3 | $68 |
Products named: TRELEGY ELLIPTA, Cologuard Collection Kit, OTEZLA, CAPLYTA, SHINGRIX, UBRELVY, QULIPTA, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
